IP-10 production

pathway activity — tumor vs normal
GO:0071612Tumor vs NormalRNA activityBox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, RNA activity of the IP-10 production pathway differs between tumor and matched normal tissue in 12 of the 18 cancer types tested.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where pathway activity is higher in tumor tissue than in matched normal tissue. In most cancer types, this pathway shows higher activity in tumors.

KIRC, KIRP, and BRCA show the most reproducible tumor–normal differences in pathway activity.

Tumor vs normal pathway activity by lineage

Ranked by sampling consensus. Activity change represents the tumor-versus-normal difference in pathway activity on a log2 scale. Positive values indicate higher pathway activity in tumor tissue. The reported p-values are derived from the corresponding differential activity tests.
LineageGenderStageActivity changepSampling consensus
KIRCMaleAll+0.117<.00112view →
KIRPMaleIII,IV+0.129<.0019view →
BRCAAllIII,IV+0.068<.0016view →
READAllAll+0.099.0025view →
STADAllAll+0.090.0025view →
LUADMaleAll+0.058.0045view →
COADMaleAll+0.056.0124view →
CHOLAllAll+0.084.0082view →
THCAMaleAll+0.051.0412view →
UCECAllAll+0.039.0382view →
KICHMaleIV+0.079.0051view →
LIHCFemaleIII,IV+0.050.0171view →
Pink = more active in tumor, green = less active in tumor. Showing the 12 strongest of 12 lineages.

Exploration